Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monica Montagnani

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
Current Pharmaceutical Design|January 9, 2009
Abnormal insulin signaling: early detection of silent coronary artery disease-erectile dysfunction?Maria Assunta Potenza, Monica Montagnani
Internal and Emergency Medicine|March 13, 2009
Molecular and clinical aspects of endothelial dysfunction in diabetesCarmela Nacci, Mariela Tarquinio, Monica Montagnani
Journal of Reproductive Immunology|August 22, 2013
The putative metabolic role of d-chiro inositol phosphoglycan in human pregnancy and preeclampsiaMarco Scioscia, Marilena Nigro, Monica Montagnani
American Journal of Physiology. Endocrinology and Metabolism|June 4, 2009
Vascular actions of insulin with implications for endothelial dysfunctionMaria Assunta Potenza, Francesco Addabbo, Monica Montagnani
Current Diabetes Reports|July 18, 2003
Molecular and physiologic actions of insulin related to production of nitric oxide in vascular endotheliumMichelle A Vincent, Monica Montagnani, Michael J Quon
Current Medicinal Chemistry|June 22, 2006
Endothelin-1: the yin and yang on vascular functionFlora Linda Marasciulo, Monica Montagnani, Maria Assunta Potenza
Molecules (Basel, Switzerland)|July 9, 2020
The Intrinsic Virtues of EGCG, an <i>Extremely Good Cell Guardian</i>, on Prevention and Treatment of Diabesity ComplicationsMaria Assunta Potenza, Dominga Iacobazzi, Luca Sgarra, et al.
Current Pharmaceutical Design|December 20, 2022
Antibiotic Resistance and Microbiota ResponseLuigi Santacroce, Marina Di Domenico, Monica Montagnani, et al.
American Journal of Physiology. Endocrinology and Metabolism|March 1, 2012
Determinants of evolving metabolic and cardiovascular benefit/risk profiles of rosiglitazone therapy during the natural history of diabetes: molecular mechanisms in the context of integrated pathophysiologyLuca Sgarra, Francesco Addabbo, Maria Assunta Potenza, et al.
Heart Failure Clinics|September 25, 2012
Role of lipotoxicity in endothelial dysfunctionJeong-a Kim, Monica Montagnani, Sruti Chandrasekran, et al.
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
Current Pharmaceutical Design|January 9, 2009
Abnormal insulin signaling: early detection of silent coronary artery disease-erectile dysfunction?Maria Assunta Potenza, Monica Montagnani
Internal and Emergency Medicine|March 13, 2009
Molecular and clinical aspects of endothelial dysfunction in diabetesCarmela Nacci, Mariela Tarquinio, Monica Montagnani
Journal of Reproductive Immunology|August 22, 2013
The putative metabolic role of d-chiro inositol phosphoglycan in human pregnancy and preeclampsiaMarco Scioscia, Marilena Nigro, Monica Montagnani
American Journal of Physiology. Endocrinology and Metabolism|June 4, 2009
Vascular actions of insulin with implications for endothelial dysfunctionMaria Assunta Potenza, Francesco Addabbo, Monica Montagnani
Current Diabetes Reports|July 18, 2003
Molecular and physiologic actions of insulin related to production of nitric oxide in vascular endotheliumMichelle A Vincent, Monica Montagnani, Michael J Quon
Current Medicinal Chemistry|June 22, 2006
Endothelin-1: the yin and yang on vascular functionFlora Linda Marasciulo, Monica Montagnani, Maria Assunta Potenza
Molecules (Basel, Switzerland)|July 9, 2020
The Intrinsic Virtues of EGCG, an <i>Extremely Good Cell Guardian</i>, on Prevention and Treatment of Diabesity ComplicationsMaria Assunta Potenza, Dominga Iacobazzi, Luca Sgarra, et al.
Current Pharmaceutical Design|December 20, 2022
Antibiotic Resistance and Microbiota ResponseLuigi Santacroce, Marina Di Domenico, Monica Montagnani, et al.
American Journal of Physiology. Endocrinology and Metabolism|March 1, 2012
Determinants of evolving metabolic and cardiovascular benefit/risk profiles of rosiglitazone therapy during the natural history of diabetes: molecular mechanisms in the context of integrated pathophysiologyLuca Sgarra, Francesco Addabbo, Maria Assunta Potenza, et al.
Heart Failure Clinics|September 25, 2012
Role of lipotoxicity in endothelial dysfunctionJeong-a Kim, Monica Montagnani, Sruti Chandrasekran, et al.
Pageof 8